Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdreView Reproducibility Study in Heart Failure
NCT01936649Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- Aug 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Iobenguane in heart failure (HF), sponsored by GE HealthCare. Primary endpoint: Test-retest Reproducibility of Iobenguane I 123 Injection Myocardial Uptake on Planar Imaging at 3 Hours 50 Minutes. Started Aug 2013; status: completed.
02
Drugs
Iobenguane
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01936649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936649.